Literature DB >> 21053117

Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues.

C Czerkinsky1, J Holmgren.   

Abstract

The mucosal immune system exhibits a high degree of anatomic compartmentalization related to the migratory patterns of lymphocytes activated at different mucosal sites. The selective localization of mucosal lymphocytes to specific tissues is governed by cellular "homing" and chemokine receptors in conjunction with tissue-specific addressins and epithelial cell-derived chemokines that are differentially expressed in "effector" tissues. The compartmentalization of mucosal immune responses imposes constraints on the selection of vaccine administration route. Traditional routes of mucosal immunization include oral and nasal routes. Other routes for inducing mucosal immunity include the rectal, vaginal, sublingual, and transcutaneous routes. Sublingual administration is a new approach that results in induction of mucosal and systemic T cell and antibody responses with an exceptionally broad dissemination to different mucosae, including the gastrointestinal and respiratory tracts, and the genital mucosa. Here, we discuss how sublingual and different routes of immunization can be used to generate immune responses in the desired mucosal tissue(s).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21053117     DOI: 10.1007/82_2010_112

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  45 in total

1.  Induction of mucosal immunity through systemic immunization: Phantom or reality?

Authors:  Fei Su; Girishchandra B Patel; Songhua Hu; Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

Review 2.  Dendritic cells of the oral mucosa.

Authors:  A-H Hovav
Journal:  Mucosal Immunol       Date:  2013-06-12       Impact factor: 7.313

Review 3.  Vaccines against enteric infections for the developing world.

Authors:  Cecil Czerkinsky; Jan Holmgren
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

4.  The middle ear immune defense changes with age.

Authors:  Michelle Christine Nielsen; Morten Friis; Tomas Martin-Bertelsen; Ole Winther; Lennart Friis-Hansen; Per Cayé-Thomasen
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-07       Impact factor: 2.503

Review 5.  Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

Authors:  Mevyn Nizard; Mariana O Diniz; Helene Roussel; Thi Tran; Luis Cs Ferreira; Cecile Badoual; Eric Tartour
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infection.

Authors:  Shailendra B Tallapaka; Bala V K Karuturi; Pravin Yeapuri; Stephen M Curran; Yogesh A Sonawane; Joy A Phillips; D David Smith; Sam D Sanderson; Joseph A Vetro
Journal:  Int J Pharm       Date:  2019-05-08       Impact factor: 5.875

Review 7.  Recent progress in mucosal vaccine development: potential and limitations.

Authors:  Nils Lycke
Journal:  Nat Rev Immunol       Date:  2012-07-25       Impact factor: 53.106

8.  In vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge model.

Authors:  Constantine Bitsaktsis; Zulfia Babadjanova; Edmund J Gosselin
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

9.  Sublingual immunization with adenovirus F protein-based vaccines stimulates protective immunity against botulinum neurotoxin A intoxication.

Authors:  Sangmu Jun; Beata Clapp; Dagmara Zlotkowska; Teri Hoyt; Kathryn Holderness; Massimo Maddaloni; David W Pascual
Journal:  Int Immunol       Date:  2011-12-29       Impact factor: 4.823

10.  Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization.

Authors:  Laura A Novotny; John D Clements; Lauren O Bakaletz
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.